Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAX8 | Q06710 | 1/20 | 0.71 |
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.65 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.57 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.57 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.57 |
| ▸ | STAT6 | P42226 | 1/20 | 0.57 |
| ▸ | GMNN | O75496 | 1/20 | 0.57 |
| ▸ | BLM | P54132 | 1/20 | 0.57 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14713455 | 1.00 | PAX8 (0.71) | PAX8SLC29A1ADORA3ADORA2AADORA1 | |
| SCHEMBL20626480 | 1.00 | PAX8 (0.71) | PAX8SLC29A1ADORA3ADORA2AADORA1 | |
| SCHEMBL21874990 | 1.00 | PAX8 (0.71) | PAX8SLC29A1ADORA3ADORA2AADORA1 | |
| SCHEMBL19583035 | 0.90 | SLC29A1 (0.64) | PAX8SLC29A1ADORA3ADORA2AADORA1 | |
| SCHEMBL19583092 | 0.90 | SLC29A1 (0.64) | PAX8SLC29A1ADORA3ADORA2AADORA1 | |
| SCHEMBL21874994 | 0.90 | SLC29A1 (0.64) | PAX8SLC29A1ADORA3ADORA2AADORA1 | |
| SCHEMBL19583009 | 0.90 | SLC29A1 (0.64) | PAX8SLC29A1ADORA3ADORA2AADORA1 | |
| SCHEMBL19583152 | 0.90 | SLC29A1 (0.64) | PAX8SLC29A1ADORA3ADORA2AADORA1 | |
| SCHEMBL19582964 | 0.90 | SLC29A1 (0.66) | PAX8SLC29A1ADORA3HIF1ATP53 | |
| SCHEMBL19583084 | 0.89 | SLC29A1 (0.63) | PAX8SLC29A1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10174033-B2 | N6-substituted adenosine derivatives and N6-substituted adenine derivatives and uses thereof | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2019-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10174033-B2 | N6-substituted adenosine derivatives and N6-substituted adenine derivatives and uses thereof | ADORA2A, ADORA3, ADORA1 | PAX8 2597/4885SLC29A1 267/4885ADORA3 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.